Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial
- 28 December 2006
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 52 (1), 134-141
- https://doi.org/10.1016/j.eururo.2006.12.029
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The combination of gemcitabine and carboplatin as first‐line treatment in patients with advanced urothelial carcinomaCancer, 2005
- Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerJournal of Clinical Oncology, 2005
- Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tractCancer, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- A feasibility study of carboplatin with fixed dose of gemcitabine in ‘unfit’ patients with advanced bladder cancerEuropean Journal Of Cancer, 2001
- Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trialEuropean Journal Of Cancer, 1999
- Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and PaclitaxelGynecologic Oncology, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958